News



8 March 2018

DEINOVE collaborates with NAICONS to discover new antibiotics in the frame of the AGIR project (Antibiotics Against Resistant Infectious Germs) Read more>


Nov. 2017 NAICONS takes part in CARTNET (Combating Antimicrobial Resistance - a training network), a project funded by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 765147. CARTNET trains young researchers in Europe to address serious and global problems of antibiotic resistance. CARTNET will focus on alternative approaches to handle antibiotic resistance and treating resistant infections in both humans and animals. For more info about project see Read more about CARTNET>


15 June 2017

NAICONS Team Discover New Antibiotic Effective against Drug-Resistant Bacteria.

Scientists from Rutgers University-New Brunswick, NAICONS and elsewhere report in Cell today the discovery and mechanism of action of a new antibiotic effective against drug-resistant bacteria.  See EurekAlert for further details>


Apr. 2017 NAICONS CEO to speak at ECCMID 2017 (Vienna 22nd – 25th April) read more>


Feb. 2017 NAICONS awards PREMIO-NAICONS read more>


Jan. 2017 NAICONS takes part in Rafts4Biotech (Synthetic bacterial lipid rafts to optimize industrial bioprocesses), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720776) For more info about project see read more about Rafts4Biotech>


Jan. 2017 NAICONS takes part in TOPCAPI (Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720793). For more info about project see read more about TOPCAPI>


Jan. 2017 NAICONS takes part in Train2Target, an European Training Network funded by the European Commission under the Horizon 2020 Marie Skłodowska-Curie Action (no. 721484). The project, which started on January 2017 and will last until December 2020, involves 11 Beneficiaries from 8 different countries and is dedicated to the scientific and professional training of 15 Early Stage Researchers (PhDs). the aim of the Train2Target programme is to deliver leads for a new generation of innovative antibacterials to treat infections by multi-drug resistant pathogens. For more info about project see read more about train2target>


Feb. 2016 "Premio NAICONS 2016" read more>


Jan. 2016 "NAICONS signs  Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance " read more>


Dec. 2015 "NAICONS Transfers Entire Fungi Collection to Koch Biological Solutions" read more>


Apr. 2015 "NAICONS joins BEAM alliance" read more>